Activities per year
Abstract
In this feature, following his participation is a workshop at the International Society for Pharmacoeconomics and Outcomes Research’s 2020 Asia Pacific meeting, Brian Godman discusses current methods used to reimburse and evaluate the cost-effectiveness of therapies, as well as challenges associated with applying these in the context of innovative therapies for rare diseases.
Original language | English |
---|---|
Type | Evidence Base feature |
Media of output | The Evidence Base Online |
Place of Publication | London |
Publication status | Published - 14 Oct 2020 |
Keywords
- pricing
- innovative therapies
- pharmacoeconomics
Fingerprint
Dive into the research topics of 'Look behind the lecture: paying for innovative therapies - why existing methods may not suffice'. Together they form a unique fingerprint.Activities
- 1 Media Participation
-
Paying for innovative therapies – why existing methods may not suffice
Godman, B. (Recipient)
14 Oct 2020Activity: Public Engagement and Outreach › Media Participation